ANAB
USDAnaptysBio Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$35.970
고가
$36.500
저가
$34.595
거래량
0.76M
기업 기본 정보
시가총액
971.8M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.52M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update
Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on track for Nov./Dec.
Anaptys Announces Participation in November Investor Conferences
SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president
Stifel Maintains Buy on AnaptysBio, Raises Price Target to $80
Stifel analyst Alex Thompson maintains AnaptysBio with a Buy and raises the price target from $55 to $80.
Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
New data reinforce rosnilimab's efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced therapy, including
관련 주식
TRNR
Interactive Strength Inc.
UFPT
UFP Technologies Inc.
SBR
Sabine Royalty Trust
BLTE
Belite Bio Inc American Depositary Shares
FAM
First Trust/abrdn Global Opportunity Income Fund Common Shares of Beneficial Interest
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기